Five IPOs and one SPAC went public this past week led by Royalty Pharma (RPRX), which completed the largest US IPO of 2020 to date. Healthcare continued to dominate, with all five IPOs coming from the sector.
Royalty Pharma priced its upsized offering at the high end to raise $2.2 billion at a $16.7 billion market cap and popped 59% on its first day of trading. The company is a global leader in the pharmaceutical royalty space, and its portfolio consists of royalties on drugs from large pharmaceuticals, research hospitals, and academic intuitions. Royalty Pharma